Since ACE inhibitors are widely prescribed for several lifestyle‐and age‐related cardiovascular indications such as hypertension, heart failure, and myocardial infarction (Mahmoudpour et al., 2018), practitioners must consider the potential negative interaction between treatment with ACE inhibitors and exercise‐induced muscle hypertrophy. The gene discussed is ACE; the disease is myocardial infarction.